Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma

Pancreatic cancer is the only major cancer with very low survival rates (1%). It is the fourth leading cause of cancer-related death. Hyperactivated growth hormone receptor (GHR) levels have been shown to increase the risk of cancer in general and this pathway is a master regulator of key cellular f...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramani, Ramadevi, Lopez-Valdez, Rebecca, Salcido, Alyssa, Boopalan, Thiyagarajan, Arumugam, Arunkumar, Nandy, Sushmita, Lakshmanaswamy, Rajkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221692/
https://www.ncbi.nlm.nih.gov/pubmed/25301264
http://dx.doi.org/10.1038/emm.2014.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221692/
https://www.ncbi.nlm.nih.gov/pubmed/25301264
http://dx.doi.org/10.1038/emm.2014.61

Ejemplares similares